Related Articles
XELIRI compared with FOLFIRI as a second‑line treatment in patients with metastatic colorectal cancer
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan‑induced toxicity in patients with cancer
UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens
Linkage disequilibrium of UGT1A1∗6 and UGT1A1∗28 in relation to UGT1A6 and UGT1A7 polymorphisms
Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population